The Nigerian unit of British drugmaker GlaxoSmithKline on Tuesday reported 2013 pretax profit up 3.4 percent to 4.31 billion naira ($26 million), from 4.17 billion naira the previous year.

Turnover grew 15.3 percent to 29.18 billion naira during the period, compared with 25.31 billion naira a year earlier, the company said in a filing with the Nigerian Stock Exchange.

Reuters

Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp